Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > WOWZERS what a Scam Artist job with Phase 1 (again more)
View:
Post by FarmerBetsy on Nov 01, 2023 6:46pm

WOWZERS what a Scam Artist job with Phase 1 (again more)

Really i looked at the half proposed Phase 1 testing paper work, could have been probably done a year ago and no Alzheimers patients just HEALTY VOLUNTEERS. Looked at the Corporate update where they had a number of 8 now 40 healty volunteers. Help me understand a little more than a year Promis said expecting to file an IND by the end of 2022, delayed months to have it early in May/2023 now heading into 7 months after approval and the couldn't do 8 healthy volunteers months ago? Now they are saying 40 healthy volunteers for 85 days REALLY ? Estimated results in July / 2024 that's an easy way of delaying another YEAR with no meaning results.

Promis - " A PHASE 1 STUDY OF PMN310 IN HEALTY VOLUNTEERS"

All other companies go into the clinic in Phase 1 actually testing some Alzheimers patients. 

"A STUDY TO EVALUATE TEH SAFETY, TOLERBILITY , AND BLOOD LEVELS IN PARTICIPANTS WITH MCI OR MILD AD'.

Promis is not interested into going into the clinic hopefully someone comes along and does a real job, Cashman and is crew are now pupits to the Boston group which i cautioned about a few years ago.
Comment by Gbathat on Nov 01, 2023 9:37pm
Its Phase 1a- checking safety, pharmicokinetics, and CSF concentration measurement Phase 1b will focus on patients mild to moderate AD and include biomarker assessments and ARIA monitoring
Comment by G1945V on Nov 02, 2023 5:15am
Surely Phase 1B would not be administered to healthy patients.  G1945V
Comment by BottomBroker on Nov 02, 2023 9:12am
That was the plan all along, to test healthy individuals first. They've been saying that for many months. This comes as no surprise. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities